Results from phase 2 study of fazirsiran in patients with alpha-1 antitrypsin deficiency published in new england journal of medicine

Osaka, japan & pasadena, calif.--(business wire)--results from phase 2 study of fazirsiran in patients with alpha-1 antitrypsin deficiency published in new england journal of medicine.
TAK Ratings Summary
TAK Quant Ranking